Method of identifying compounds using a transgenic pig model of cystic fibrosis
US7989675B2 · kind B2 · utility
8Cited by
5References
2Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 5, 2008 |
| Grant date | Aug 2, 2011 |
| Priority date | — |
| Expiry date | Oct 28, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA01K2267/0306
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention provides transgenic, large non-human animal models of diseases and conditions, as well as methods of using such animal models in the identification and characterization of therapies for the diseases and conditions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.